| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.5M | — | -86.2% |
| R&D Expense | $64.7M | — | +10.4% |
| SG&A Expense | $17.7M | — | +2.1% |
| Operating Income | -$77.9M | — | -80.3% |
| Pre-tax Income | -$128.6M | — | -166.5% |
| Income Tax | $280K | — | -23.7% |
| Net Income | -$128.9M | — | -166.3% |
| EPS (Basic) | -$1.71 | — | -159.1% |
| EPS (Diluted) | -$1.71 | — | -159.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.2M | -73.8% | -64.3% |
| Accounts Receivable | $12.0M | -59.0% | -68.2% |
| Current Assets | $482.9M | -19.5% | -7.4% |
| Total Assets | $736.8M | -15.8% | -18.6% |
| Current Liabilities | $73.5M | -23.4% | -16.9% |
| Long-term Debt | $82.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$67.6M | — | -316.9% |
| Capital Expenditures | $610K | — | -57.8% |
| Investing Cash Flow | $26.7M | — | +95.2% |
| Financing Cash Flow | $950K | — | -23.9% |
| Free Cash Flow | -$68.2M | — | -286.3% |
| -19.4% |
| Total Liabilities | $221.2M | -7.8% | -16.5% |
| Stockholders' Equity | $515.6M | -18.9% | -19.4% |